Product Details
HeartInsight — Being One Step Ahead Can Make All the Difference
HeartInsight shifts heart failure management from detection to prediction to allow clinical teams to focus their valuable time on those who need them the most.
Heart failure is a leading cause of hospitalizations, and each hospitalization reflects a deteriorating prognosis for the patient.1,2 Managing heart failure patients is complex and requires significant resources.3 Health care providers face the difficult tasks of reducing costs and preventing hospitalizations through early identification and care of at-risk patients.
HeartInsight is a premium remote heart failure management solution that identifies patients at higher risk of decompensation early on. HeartInsight predicts heart failure hospitalizations — automatically and with high sensitivity — by combining multiple parameters into a single composite score, leading to one actionable alert. Industrywide it has the lowest false-alert rate and provides the earliest notifications of silent clinical changes that may lead to heart failure hospitalizations.4,5
HeartInsight streamlines your work by accurately identifying at-risk patients early on, so you can proactively care for those who need you the most. This may ultimately result in improved patient outcomes, as well as reduced clinical burden and costs associated with heart failure management.
Predicting 2 out of 3 heart failure hospitalizations
Alert time (median)
Only 1 false alert every 17 months
HeartInsight shifts heart failure management from detection to prediction to allow clinical teams to focus their valuable time on those who need them the most.
For Identifying Patients at Higher Risk of Worsening Heart Failure
Receiving multiple inaccurate alerts with vague actionability is inefficient and time-consuming. HeartInsight is different: It provides a single alert to support confident decision making. This enables you to spend less time on false alerts and focus on the patients that need you most.
For Collecting Self-Assessment Information Relevant to Heart Failure
Engaging patients and contacting them to collect clinical information can be challenging and resource-intensive. The Patient App is designed to engage patients to provide behavioral and symptom information by automatically prompting collection of this data. This supports patient management and may free up your time for other tasks.
For Supporting Confident Decision Making
With a growing cardiac device population, gathering and interpreting data to determine patient status is becoming more cumbersome and complex. HeartInsight helps streamline this process by organizing information clearly and intuitively. Through incorporation of patient-reported data from the Patient App, HeartInsight enables you to correlate signs and symptoms – intended to support patient assessment.
For Initiating a Meaningful Change
Heart failure patients often present with serious complications, highlighting the need for proactive care. HeartInsight provides a predictive alert to give you more time for contacting patients and initiating meaningful change. This may improve patient outcomes and reduce costly hospitalizations.
SELENE HF Multi-Center Study
The SELENE HF study assessed more than 900 patients and validated that the HeartInsight algorithm provides sensitive and timely prediction of impending heart failure decompensation with a low false-alert rate.
Key Findings
All-in-One Alert
8 parameters combined into one score and trend.
HeartInsight’s sophisticated algorithm automatically combines 8 highly HF-relevant parameters in one score. When the score crosses a configurable threshold, HeartInsight provides a single, predictive alert identifying patients at higher risk of worsening heart failure. It is intended to allow clinical teams to care proactively and initiate a meaningful change, even before patients may report symptoms.
This may ultimately result in improved patient outcomes, decreased clinical burden, and reduced costs associated with heart failure management.
Facilitate trapping of OTW devices with Guidion Short!1
Enable trapping techniques of OTW devices in...
Reduce the risk of pressure damping and procedure induced ischemia1. FlowGuide has 9 circumferential...
Working alongside physicians and listening closely to their needs, we have together developed a...
A real challenge exists in the clinical world today with the volume of data generated as more...
Personal radiation protection devices used to protect from harmful ionizing radiation are sometimes...
The growing number and complexity of fluoroscopic procedures performed each year has increased the...
Indicated for de novo coronary artery lesionsa
Support
Resorbable coronary scaffolds widen coronary...
With a 30% non-response rate to CRT1 , therapy optimization is essential for clinicians taking care...
For many years, patients with a pacemaker, ICD or CRT device, have been denied access to MRI. The...
Indicated for improving arterial luminal diameter in patients with clinical symptoms attributable to...
Indicated to provide access into the femoral, popliteal and infrapopliteal arteries.*
The all-in-one solution to reach, cross and prepare lesions.1 One Solution: Multiple functions...
Over the years, BIOTRONIK kept on innovating and improving ICD leads, having in mind long-term...
Indicated for use in patients with atherosclerotic disease of the iliac arteries and for the...
Guidion Hydro guide extension catheter has a radiopaque soft tip for true distal end visibility...
Pantera Lux Coronary Drug-Coated Balloon (DCB) is indicated for balloon dilatation for in-stent...
Indicated for central and peripheral circulatory system including saphenous vein grafts.a
PK Papyrus covered coronary stent is indicated for acute coronary artery perforations.a Delivers...
Orsiro Mission DES is indicated for improving coronary luminal diameter in patients with symptomatic...
BIOTRONIK has a long history of excellence in product design and performance and adheres to high...
The crossability of ReCross microcatheter is comparable to best in class antegrade single lumen...
The Renamic Neo programmer offers complete connectivity and a long battery runtime to enable mobile...
BIOTRONIK has an unsurpassed legacy of providing high-quality therapy solutions. We cultivate the...
Indicated for use in patients with atherosclerotic disease of the femoral and proximal popliteal...
Sentus OTW QP is a family of left-ventricular (LV) quadripolar (QP) leads designed to be easily...
TrapIT trapping balloon catheter is designed to trap wires within guiding catheters securely for an...
With its rapid exchange (Rx) delivery lumen and the additional over the wire (OTW) lumen NHancer Rx...
The Renamic programmer is the result of intensive collaboration between BIOTRONIK engineers and...
For BIOTRONIK, the status quo is never enough: as a company founded by engineering principles, we...
For several decades, BIOTRONIK has consistently demonstrated innovation and excellent quality within...
Solia pacing leads comprise a complete portfolio of MR conditional active and passive pacing leads...
Indicated for balloon dilatation of the stenotic portion of a lower limb artery for the purpose of...
Passeo-35 HP is a unique high pressure PTA Balloon to dilate most resistant lesions in complex...
Indicated for stent post-dilatation and dilatation of a coronary artery or bypass graft stenosis.*
With usable lengths up to 170cm, Dynetic-35 stent system allows a radial approach for the treatment...
Passeo-18 is indicated to dilate stenosis in the femoral, popliteal and infrapopliteal arteries and...
Indicated to promote the rapid control of bleeding and provide hemostasis at the skin surface.a
With usable lengths up to 170cm, Passeo-35 Xeo balloon allows a radial approach1 to dilate stenosis...
The AlCath LT G FullCircle catheter with its unique long GoldTip is availble in various curve sizes...
The Passeo-18 Lux Drug-Coated Balloon is indicated to dilate de novo or restenotic lesions in the...
Pulsar-18 T3 is the first clinically-proven thin strut stent mounted on a tri-axial low profile (4F)...
Improving treatment and reducing risk for up to 15 years1
For patients with arrhythmias, ICD...
The AlCath G FullCircle catheter is availble in various curve sizes with FullCircle (> 180°)...
The AlCath Flux G eXtra irrigated ablation catheter has a unique gold tip, FullCircle (> 180°)...
Designed specifically for treating atrial flutter, this 95cm-long catheter is optimized for ablating...
The Qiona irrigation pump is the perfect addition to the ablation setup. It features adjustable low...
BIOTRONIK’s cardiac stimulation device Qubic Stim represents the high quality in manufacturing...
The catheters of the ViaCath family are steerable, multipolar diagnostic catheters for intracardiac...
Designed specifically for treating atrial flutter, this 95cm-long catheter is optimized for ablating...
The catheters of the MultiCath family are pre-shaped, multipolar diagnostic catheters for...
Edora 8 CRT pacemakers take CRT a step further than implantation and therapy, enabling unique...
Simplified and optimized CRT for up to 9 years1
Heart failure is tough to live with and can be...
Indicated for dilatation of coronary artery or bypass graft stenosis.a
For more than 50 years, BIOTRONIK has consistently demonstrated innovation and excellent quality...
Small, Enduring, Complete, Smart — Edora 8 pacemakers combine small size with a complete suite of...
The Amvia Sky pacing system gives you choices. Take advantage of a broader range of treatment...
With the BIOTRONIK Patient App, your patients can be involved in the management of their condition...
The mobile CardioMessenger Smart looks like a smartphone and can be used on the go for up to 48...
Taking care of cardiac device patients can be challenging. The BIOTRONIK remote monitoring system is...
A Support Microcatheter indicated for the exchange and support of guidewires into peripheral...
1. Ambrosy AP et al. The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries. J Am Coll Cardiol 2014; 63:1123–33.; 2. Gheorghiade M et al. Pathophysiologic Targets in the Early Phase of Acute Heart Failure Syndromes. Am J Cardiol; 2005; 96:11G–17G.; 3. Ponikowski Pet al. HF preventing disease and death worldwide. ESC Heart Fail 2014 Sep;1(1):4–25.; 4. Comparison of alerting time in validation studies: D’Onofrio et al. Europace 2021 doi:10.1093/europace/euab170; Boehmer JP et al. J Am Coll Cardiol Heart Fail. 2017 Mar, 5 (3) 216–225; Cowie MR et al. European Heart Journal (2013) 34, 2472–2480 doi:10.1093/eurheartj/eht083.; 5. Comparison of false alert rate in validation studies: D’Onofrio et al. Europace 2021 doi:10.1093/europace/euab170; Boehmer JP et al. J Am Coll Cardiol Heart Fail. 2017 Mar, 5 (3) 216–225; Cowie MR et al. European Heart Journal (2013) 34, 2472–2480 doi:10.1093/eurheartj/eht083.; 6. D’Onofrio A et al. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalisations: results from the SELENE HF study. Europace 2021 doi: 10.1093/europace/euab170.; 7. Home Monitoring daily parameters combined with 1 baseline risk stratifier based on the Seattle Heart Failure Model (Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M, 2006. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation, 113:1424-1433.); 8. Data on file.
* 42 days refers to median alert time.
** Available for Acticor/Rivacor, Ilivia Neo/Intica Neo, Ilivia/Intica /Inlexa -5 and -7 series ICD DX/DC and CRT-D.
*** Based on current standard practice and clinical judgement
Disclaimer: HeartInsight is approved and available in CE regions only.